葉 裕民

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Neoplasms 51%
3. Mutation 31%
4. Peripheral Nervous System Diseases 27%
5. Cell-Free Nucleic Acids 25%
6. Survival 24%
7. Drug Therapy 18%
8. Artificial Intelligence 17%
9. human ERBB2 protein 16%
10. Lung Neoplasms 15%
11. pembrolizumab 15%
12. Genes 14%
13. Therapeutics 14%
14. Endometrial Neoplasms 14%
15. Paclitaxel 13%
16. High-Throughput Nucleotide Sequencing 12%
17. ADI PEG20 12%
18. Gene Expression 12%
19. N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide 11%
20. ran GTP-Binding Protein 11%
21. interleukin 20 10%
22. cathepsin S 10%
23. Tumor Microenvironment 10%
24. betulinic acid 10%
25. nucleolin 9%
26. Lymphoma, Large B-Cell, Diffuse 9%
27. Minoxidil 9%
28. B-Cell Lymphoma 9%
29. Castleman Disease 9%
30. Lapatinib 9%
31. Machine Learning 9%
32. Hereditary Nonpolyposis Colorectal Neoplasms 9%
33. Colony-Stimulating Factor Receptors 9%
34. Chelation Therapy 9%
35. GTPase-Activating Proteins 8%
36. Network Meta-Analysis 8%
37. Hemophagocytic Lymphohistiocytosis 8%
38. Proteins 8%
39. Polycythemia Vera 8%
40. Tight Junction Proteins 8%
41. Capecitabine 8%